NCT00291694View on ClinicalTrials.gov

Protocol for Women at Increased Risk of Developing Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

April 30, 2003

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Breast Cancer
Interventions
DRUG

celecoxib

Celecoxib 400 mg BID

OTHER

placebo

placebo

Trial Locations (1)

66160

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

Susan G. Komen Breast Cancer Foundation

OTHER

lead

Carol Fabian, MD

OTHER

NCT00291694 - Protocol for Women at Increased Risk of Developing Breast Cancer | Biotech Hunter | Biotech Hunter